Lihao Meng
Impact in
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways
- Protein Degradation and Inhibitors
- Signaling Pathways in Disease
- Chemical Synthesis and Analysis
Papers in
-
- Synthesis and Biological Activity 1
- Oncology 5
- Peptidase Inhibition and Analysis 5
- Co-authors
- Ny SinCraig M. CrewsMikael ElofssonBenjamin H. KwokRoyce MohanJames WenWilliam G. BornmannErik Floor
- Journals
- Proceedings of the National Academy of Sciences (2 papers)Bioorganic & Medicinal Chemistry (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Biochemistry (1 paper)BMC Biotechnology (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Lihao Meng
12 papers receiving 1.7k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 645
- Molecular Biology 1.3k
- Cancer Research 207
- Cellular and Molecular Neuroscience 236
- Cell Biology 203
Countries citing papers authored by Lihao Meng
This map shows the geographic impact of Lihao Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lihao Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lihao Meng more than expected).
Fields of papers citing papers by Lihao Meng
This network shows the impact of papers produced by Lihao Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lihao Meng. The network helps show where Lihao Meng may publish in the future.
Co-authorship network
The 22 scholars most cited alongside Lihao Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 9 | |
| 2 | 2012 | 1 | |
| 3 | 2010 | 14 | |
| 4 | 2009 | 1 | |
| 5 | 2008 | 21 | |
| 6 | 1999 | 164 | |
| 7 | Epoxomicin, a potent and selective proteasome inhibitor, exhibitsin vivoantiinflammatory activity Hit paper breakdown → | 1999 | 803 |
| 8 | 1998 | 50 | |
| 9 | 1998 | 31 | |
| 10 | The anti-angiogenic agent fumagillin covalently binds and inhibits the methionine aminopeptidase, MetAP-2 Hit paper breakdown → | 1997 | 530 |
| 11 | 1996 | 41 | |
| 12 | 1995 | 71 |
About Lihao Meng
Lihao Meng is a scholar working on Cancer Research, Oncology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Cellular and Molecular Neuroscience, having authored 12 papers that have together received 1.7k indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (5 papers), Advanced Biosensing Techniques and Applications (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Advanced biosensing and bioanalysis techniques (3 papers), Signaling Pathways in Disease (2 papers), Ubiquitin and proteasome pathways (2 papers), Neuroscience and Neuropharmacology Research (2 papers) and Synthesis and Biological Activity (1 paper). The work is most often cited by research in Oncology (645 citations), Molecular Biology (1.3k citations), Cancer Research (207 citations), Cellular and Molecular Neuroscience (236 citations) and Cell Biology (203 citations). Lihao Meng has collaborated with scholars based in United States and China. Frequent co-authors include Ny Sin, Craig M. Crews, Mikael Elofsson, Benjamin H. Kwok, Royce Mohan, James Wen, William G. Bornmann, Erik Floor, Kyung Bo Kim and Weiqing Chen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Bioorganic & Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Biochemistry and BMC Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.